Lexaria Bioscience Corp. announced it has signed contracts with a contract research organization (CRO) to begin Human Pilot Study #7 (GLP-1-H26-7), evaluating oral DehydraTECH-processed GLP-1 formulations. The... The post Lexaria Bioscience Signs CRO Contracts for New GLP-1 Human Study appeared first on PharmaSource .
Lexaria Bioscience Signs CRO Contracts for New GLP-1 Human Study